Psilocybin as a Treatment for Chronic Pain in Smokers | MicrobiomeTrials← Back to trialsNCT07118332
Psilocybin as a Treatment for Chronic Pain in Smokers
RecruitingEARLY_PHASE1INTERVENTIONAL
Trial Details
Start: 2026-07Est. Completion: 2027-10-01
Enrollment target: 10 participants Locations- Department of Veterans Affairs, West Haven, Connecticut, United States
Other microbiome trials you might be interested in
Carbon Monoxide, Pain Perception, Sensory Thresholds, Anxiety, Depression, Tobacco Smoking
Carbon monoxide (CO) is a colorless and odorless gas that can enter the human body through environmental exposure and es…
Multiple LocationsEst. completion Jul 1, 2026
SmokingPainSmoking Cessation
PASS2 aims to expand upon the recently completed study (PASS intervention), which tested the telephone delivery of a cog…
West Haven, United StatesEst. completion May 31, 2028